BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 83 filers reported holding BICYCLE THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,647 | -9.0% | 82,000 | +15.7% | 0.00% | 0.0% |
| Q2 2023 | $1,809 | +37.4% | 70,900 | +14.5% | 0.00% | +50.0% |
| Q1 2023 | $1,317 | -99.9% | 61,900 | -59.6% | 0.00% | -33.3% |
| Q2 2022 | $2,571,000 | -9.0% | 153,200 | +137.9% | 0.00% | 0.0% |
| Q1 2022 | $2,826,000 | -36.6% | 64,399 | -12.0% | 0.00% | -50.0% |
| Q4 2021 | $4,454,000 | +905.4% | 73,179 | +401.2% | 0.01% | +500.0% |
| Q2 2021 | $443,000 | -44.7% | 14,600 | -45.5% | 0.00% | 0.0% |
| Q1 2021 | $801,000 | -45.1% | 26,800 | -67.0% | 0.00% | -50.0% |
| Q4 2020 | $1,458,000 | +28.7% | 81,200 | +36.5% | 0.00% | +100.0% |
| Q3 2020 | $1,133,000 | -3.7% | 59,500 | -20.3% | 0.00% | 0.0% |
| Q2 2020 | $1,176,000 | +357.6% | 74,700 | +297.3% | 0.00% | – |
| Q1 2020 | $257,000 | – | 18,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 3,642,307 | $73,173,948 | 4.96% |
| Sio Capital Management, LLC | 796,933 | $16,010,384 | 4.96% |
| First Light Asset Management, LLC | 2,070,853 | $41,603,437 | 3.95% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,281,820 | $25,751,764 | 3.60% |
| Deep Track Capital, LP | 3,490,506 | $70,124,266 | 2.71% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,010,976 | $20,310,508 | 1.10% |
| HighVista Strategies LLC | 92,434 | $1,856,999 | 0.86% |
| BRAIDWELL LP | 1,289,872 | $25,913,528 | 0.82% |
| DAFNA Capital Management LLC | 122,200 | $2,454,998 | 0.76% |
| Soleus Capital Management, L.P. | 391,800 | $7,871,262 | 0.73% |